Skip to content

Author

M. Sahib

We have 2 of 8 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Structure-based virtual screening and lead identification of novel protein kinase inhibitors through integrated computational approaches

Results presented show that C48 is an attractive scaffold for the future development of selective BCR-ABL type-II inhibitors targeting the inactive DFG-out conformation, and is confirmed by DFT calculations, indicating suitability for stable intermolecular interactions.

M. Sahib · 0 citations
Open access Aug 2026

Nicotinamide Riboside Attenuates Cisplatin-Induced Hepatorenal Toxicity Through Restoration of NAD+ Homeostasis and Nrf2/NQO1-Dependent Antioxidant Signaling

Nicotinamide riboside exerts protective effects against cisplatin-induced hepatorenal toxicity that are mechanistically linked to activation of the Nrf2/NQO1 antioxidant pathway and restoration of hepatic NAD+ homeostasis.

W. Albahadly, M. Rasool, H. Al-Saedi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.